• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Zhonghua Jie He He Hu Xi Za Zhi. Early detection and disease assessment of patients with novel coronavirus pneumonia

tetano

Editor, Senior Moderator
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):167-170. doi: 10.3760/cma.j.issn.1001-0939.2020.03.003. [h=1][Early detection and disease assessment of patients with novel coronavirus pneumonia].[/h]
[Article in Chinese; Abstract available in Chinese from the publisher]

Zhou L[SUP]1[/SUP], Liu HG.
[h=3]Author information[/h]

[h=3]Abstract[/h] in English, Chinese
In December 2019, the outbreak of novel coronavirus (2019-nCoV) in Wuhan, China, attracting attention worldwidely. The novel coronavirus has the characteristics of rapid transmission, atypical clinical symptoms, and easy to affect both lungs, leading to missed diagnosis and misdiagnosis, as well as difficult to detection and assessment at early stage. Fever, cough, myalgia, weakness, dyspnea and imagings may be helpful for the early detection of novel coronavirus pneumonia. At the same time, the rate of disease progression, fever, CT manifestations, hypoxia degree, age, basic diseases, and laboratory indicators can also be used to evaluate the severity of the novel coronavirus pneumonia.


[h=4]KEYWORDS:[/h] 2019 novel coronavirus (2019-nCoV); Disease assessment; Early detection

PMID: 32164079 DOI: 10.3760/cma.j.issn.1001-0939.2020.03.003
 
Back
Top Bottom